Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.
Also called NCT02351050
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 144 participants
- Sponsor
- Registry
-
NCT02351050
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Slovakia
- Registry status
- Completed
Technical summary
Registry record NCT02351050. Randomized; single masking; primary purpose prevention. Start 2015-04 (actual); primary completion 2017-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Sonolysis
- Intervention (Other)
- Sham procedure
- Lead sponsor
- University Hospital Ostrava
Record details
- Record id
cardio:ct-nct02351050- Content hash
9fe18316283db17d1e7394ac457cf042ec898c270f9c3164271e95cc725dffd0